Tennessee Oncology
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
2012 · Suzanne L. Topalian, F. Stephen Hodi, et al. · New England Journal of Medicine
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · H. Borghaei, L. Paz-Ares, et al. · New England Journal of Medicine
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
2015 · Julie R. Brahmer, Karen L. Reckamp, et al. · New England Journal of Medicine